Evidence map›Paper›PMID 42162536›Full record

ArticleOncology and therapy2026

Role and Characteristic of Multidisciplinarity in Hepatocellular Carcinoma Management and Care Pathway Certification: Bottom-Up Approach of the MDT Project in Italy.

Giuseppe Cabibbo, Caterina Cocuzza, Ciro Celsa, Maria Rosaria Attanasio, Antonio Avallone, Rossana Berardi, Roberto Bordonaro, Mariafiorella Brangi, Fabio Cartabellotta, Desiree Lucy Anna Rita Caudullo and 22 more

Abstract read
In one paragraph

Article in Oncology and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Giuseppe CabibboSection of Gastroenterology and Hepatology, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy. giuseppe.cabibbo@unipa.it.ORCID http://orcid.org/0000-0002-0946-3859
Caterina CocuzzaUOC Internal Medicine and Hepatology, ARNAS Garibaldi-Nesima Catania, Catania, Italy.
Ciro CelsaSection of Gastroenterology and Hepatology, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy.
Maria Rosaria AttanasioU.O.C. Di Gastroenterologia - AORN Cardarelli, Naples, Italy.
Antonio AvalloneExperimental Clinical Abdominal Oncology Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Naples, Italy.
Rossana BerardiOncological Clinic, Università Politecnica delle Marche, AOU delle Marche, Ancona, Italy.
Roberto BordonaroU.O.C. Medical Oncology, ARNAS Garibaldi-Nesima, Catania, Italy.
Mariafiorella BrangiUOC Oncology, AORN Cardarelli, Naples, Italy.
Fabio CartabellottaUOC Internal Medicine and Pneumology, Hospital Buccheri La Ferla, Fatebenefratelli, Palermo, Italy.
Desiree Lucy Anna Rita CaudulloU.O.C. Medical Oncology, ARNAS Garibaldi-Nesima, Catania, Italy.
Bruno DanieleUOC Oncology, Ospedale del Mare, Naples, Italy.
Giovan Giuseppe Di CostanzoLiver Unit, AORN Cardarelli, Naples, Italy.
Piera FedericoUOC Oncology, Ospedale del Mare, Naples, Italy.
Giovanni GalatiInternal Medicine and Hepatology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy.
Salvatore GruttadauriaDepartment Abdominal Center, UPMC (University of Pittsburgh Medical Center), Palermo, Italy.
Francesco IzzoS.C. Hepatobiliary Oncological Surgery - Istituto Tumori of Naples, IRCCS Fondazione "G.Pascale", Naples, Italy.
Anna NappiExperimental Clinical Abdominal Oncology Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Naples, Italy.
Giuseppina PacellaOperative Research Unit of Radiology and Interventional Radiology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy.
Mauro PiccirilloS.C. Hepatobiliary Oncological Surgery - Istituto Tumori of Naples, IRCCS Fondazione "G.Pascale", Naples, Italy.
Ferdinando RiccardiUOC Oncology, AORN Cardarelli, Naples, Italy.
Laura SchiadàSOSD Liver Damage and Transplants - AOU Delle Marche, Ancona, Italy.
Marta SchirripaUOC Oncology, Ospedale Belcolle, Asl Viterbo, Viterbo, Italy.
Marianna SillettaOperative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy.
Gianluca Svegliati BaroniSOSD Liver Damage and Transplants - AOU Delle Marche, Ancona, Italy.
Emiliano TamburiniDepartment of Oncology and Palliative Care, Hospital C. Panico, Tricase, Italy.
Raffaella TortoraLiver Unit, AORN Cardarelli, Naples, Italy.
Martina AssantiIQVIA, Milano, Italy.
Francesco DeligiosIQVIA, Milano, Italy.
Giada LodoloIQVIA, Milano, Italy.
Luca PintoIQVIA, Milano, Italy.
Maurizio RusselloUOC Internal Medicine and Hepatology, ARNAS Garibaldi-Nesima Catania, Catania, Italy.
M. D. T. Project Working Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionHepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide, requiring a multidisciplinary approach for effective management. The MDT Project aimed to define and pilot a structured care model for HCC management in Italy, supported by the implementation of integrated care pathways (ICPs), to standardize organizational processes and ensure the organizational requirements needed for appropriate patient management.

methodsA multi-phase approach included a narrative review, semi-structured interviews with national experts, and the development of an optimal care model operationalized through a maturity model with 15 organizational elements. A total of 13 hospitals, selected to reflect national heterogeneity, participated in a pilot phase involving tailored action plans and hospital-specific ICPs. In total, ten hospitals proceeded to ICP implementation, and eight achieved certification by an external accreditation body. An expert consensus meeting subsequently validated the care model, key performance indicator (KPI) panel, and assessment tools. Organizational changes were assessed pre- and post intervention through the maturity model evaluation and a survey capturing clinicians' perceptions.

resultsOrganizational improvements were observed primarily in areas directly targeted by the action plans, including the formalization of care-flow processes, multidisciplinary team structuring, case management, and coordination processes. More limited progress was seen in information systems and KPI monitoring, which require structural investments. Clinicians perceived the certification process as helpful in consolidating procedural standardization and documentation quality.

conclusionsThe MDT Project piloted an organizational model for HCC management in Italy, focusing on care-pathway governance, multidisciplinary coordination, and center readiness. These findings represent an initial step toward broader implementation; future phases should incorporate clinical outcomes and patient-reported measures to evaluate the model's long-term impact.

Indexed as

Case managementHepatocellular carcinomaIntegrated Care Pathway CertificationMultidisciplinary approachOncologyOrganizational improvement

Identifiers

PMID42162536
PMCPMC13303994

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.